Delivery Order SPE2DR25D3401-SPE2DR26FL1JP
- Not listed
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Epinephrine 0.3 mg auto-injector, 2-pack units, with a ceiling value of $2,277.60 and an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order represents a small-value transaction typical of the company's pharmaceutical supply operations supporting federal medical procurement needs. The...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 28, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs at a ceiling value of $1,402.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. This delivery order is...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 28, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $18,707.12. The contract is a firm fixed-price delivery order with an ultimate completion date of January 29, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for Epinephrine 0.3 mg auto-injector 2-packs, valued at $1,797.24 with a firm fixed-price structure. The order, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a routine medical supply procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of epinephrine 0.3 mg auto-injector packs (two-count units) with a ceiling value of $1,923.88. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, and scheduled for completion by January 23, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $2,967.41. The contract is a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and will be performed in Conshohocken, Pennsylvania. This award was not set aside for any specific business type, indicating open and competitive procurement. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (via its parent company Cencora, Inc.) on January 9, 2026, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $11,167.12 and an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical distributor will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,683.32 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 15, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by January 16, 2026, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement typical...
- The Defense Logistics Agency awarded a $2,277.36 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by January 23, 2026. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL1JPDelivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on February 2, 2026, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $1,198.16. This firm fixed-price delivery order, set to be completed by February 3, 2026, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award vehicle valued at $999,999,999.00 through December 31, 2031, which serves as the primary contracting mechanism for comprehensive pharmaceutical and medical supply deliveries to military healthcare programs globally. Cencora and its subsidiaries have demonstrated substantial capability in federal medical procurement, supplying specialty medications, brand-name and generic drugs, vaccines, medical devices, and critical care materials across multiple therapeutic domains. No set-aside designation was applied to this competitive award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/1/26 |